Indeed, the percentage of CD44+CD117+ cells was significantly lower in tumor harvested from combined-treated mice (carboplatin+chloroquine) compared with untreated or single-treated mice (Figure 4g, left panel). The gene discussed is CD44; the disease is neoplasm.